Last 29.20
Change Today 0.00 / 0.00%
Volume 258.4K
As of 6:58 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

micromedic technologies ltd (MCTC) Snapshot

Open
$29.20
Previous Close
$29.20
Day High
$29.20
Day Low
$27.50
52 Week High
03/26/14 - $129.60
52 Week Low
12/30/14 - $15.60
Market Cap
13.0M
Average Volume 10 Days
483.7K
EPS TTM
$-0.32
Shares Outstanding
44.4M
EX-Date
06/9/03
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MICROMEDIC TECHNOLOGIES LTD (MCTC)

Related News

No related news articles were found.

micromedic technologies ltd (MCTC) Related Businessweek News

No Related Businessweek News Found

micromedic technologies ltd (MCTC) Details

Micromedic Technologies Ltd. develops and commercializes cancer diagnostics products in Israel. The company’s portfolio of cancer and cancer-related indications include colorectal cancer, breast cancer, cervical cancer, bladder cancer, and lung cancer, as well as diagnostic tools for personalized treatment. It also offers Colon MarCarePlex, a molecular biomarker assay for the detection of cancerous and precancerous colorectal lesions; and mCRC-Strat, a semi quantitative immunohistochemical assay that employs protein biomarker combinations. The company is based in Tel Aviv, Israel.

micromedic technologies ltd (MCTC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

micromedic technologies ltd (MCTC) Key Developments

Micromedic Technologies Ltd Reports Successful Clinical Study Results for Monitoring Bladder Cancer Recurrence with the CellDetect® Non-Invasive Test

Micromedic Technologies Ltd. announced the results of a blinded, multi-center clinical study using the CellDetect® non-invasive technology to detect bladder cancer recurrence in patients with a history of the disease. The CellDetect® test successfully identified cancerous cells in urine samples, with reported sensitivity of 84.4% and specificity of 82.7% for the study's primary endpoint. The blinded clinical study was conducted in nine medical centers, where urine samples from 217 subjects with a history of bladder cancer were tested. The study population included 121 healthy subjects and 96 patients currently suffering from the disease. The results of the CellDetect® urine test were compared with results from biopsy or cystoscopy, in cases where biopsies were not performed. The results also indicated that the negative predictive value (NPV) was 98.5%. In addition to its high sensitivity for advanced stage tumors and high-grade malignancy, the test was also found to exhibit high sensitivity for early stage tumors and low-grade malignancies which are difficult to identify using other non-invasive tests currently available on the market. The secondary endpoint showed that the sensitivity of other non-invasive comparator tests, urine cytology, BTA stat and NMP22 BladderCheck, was 50.0%, 68.8% and 17.4%, respectively. These findings indicate that the method is adequately sensitive for the purpose of accurate and early detection of the recurrence of the disease. Following these successful study results, the company plans to secure a CE mark approval for a European launch of this non-invasive test later this year as well as to submit a Pre-IDE to the U.S. Food and Drug Administration (FDA).

Micromedic Technologies Ltd, Special/Extraordinary Shareholders Meeting, Dec 15, 2014

Micromedic Technologies Ltd, Special/Extraordinary Shareholders Meeting, Dec 15, 2014., at 11:00 Israel Standard Time.

Micromedic Technologies Ltd. Announces Trial of its Product

Micromedic Technologies Ltd. has announced that a trial of its product for detecting cervical cancer at the Beijing military hospital showed that the product marks cancer cells, thereby rendering the diagnostic process more effective.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MCTC:IT 29.20 0.00

MCTC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MCTC.
View Industry Companies
 

Industry Analysis

MCTC

Industry Average

Valuation MCTC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MICROMEDIC TECHNOLOGIES LTD, please visit www.m-medic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.